86% Of Patients With Dry Eye Have MGD
Research has determined that the leading cause of eye discomfort for over 86% of patients with dry eye is related to blockage of the tiny glands in our eyelids known as meibomian glands, and not necessarily due to a lack of tear production. When you blink, the glands release an essential oil that acts as the front line of protection for tears lubricating the surface of the eyes. When these glands become blocked, the production of the necessary oils to protect the watery layer on the tear film is compromised and causes the watery layer to evaporate and leave the eye surface exposed.
Lipiflow, A Proven MGD Treatment
The clinical science behind MGD as the primary cause of dry eye and its treatment is supported by over 25 years of scientific research. Gland blockages can be removed to restore proper gland function and reduce the progression of MGD, provided your gland structure is healthy. LipiFlow is the only FDA cleared treatment that properly heats the inside and outside of the eyelids while providing a gentle massaging action to properly remove gland blockages. Most patients receiving treatment notice improvement with symptoms over time but may need regular treatment every 1-2 years. The treatment is virtually painless and takes less than 12 minutes.